Terson Syndrome 

  • Author: Richard J Ou, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Apr 20, 2010
 

Background

In 1881, Litten first described an intraretinal hemorrhage associated with subarachnoid hemorrhage in the German literature.[1] However, Terson's description of vitreous hemorrhage following subarachnoid hemorrhage in 1900 is now associated with this syndrome.

Next

Problem

Terson syndrome originally was defined by the occurrence of vitreous hemorrhage in association with subarachnoid hemorrhage. Terson syndrome now encompasses any intraocular hemorrhage associated with intracranial hemorrhage and elevated intracranial pressures. Intraocular hemorrhage includes the development of subretinal, retinal, preretinal, subhyaloidal, or vitreal blood. The classic presentation is in the subhyaloidal space.

Previous
Next

Epidemiology

Frequency

Reports have shown an incidence of 10-50% of intraocular hemorrhage with subarachnoid hemorrhage. This association is statistically associated with the severity of the subarachnoid hemorrhage based on the Hunt-Hess classification system of subarachnoid hemorrhages. The incidence of vitreous hemorrhage is much lower (3-13%). Papilledema and unconsciousness are both positively correlated with Terson syndrome.

Previous
Next

Etiology

Terson syndrome has been described most commonly in subarachnoid hemorrhages due to ruptured cerebral aneurysms. Although early studies attempted to link this syndrome with aneurysms of the anterior communicating artery, statistical analysis has not correlated it with a specific aneurysmal location. Other reports include such causes as strangulation, trauma, tumor, perioperative, and postoperative intracranial bleeding.

Right eye of a 28-year-old female with subarachnoiRight eye of a 28-year-old female with subarachnoid hemorrhage 1 week after intracranial surgery. Left eye of a 28-year-old female with subarachnoidLeft eye of a 28-year-old female with subarachnoid hemorrhage 1 week after intracranial surgery.
Previous
Next

Pathophysiology

The pathogenesis of Terson syndrome has been controversial. The earliest reports assumed that the intracerebral blood directly connected with the intraocular space through the lamina cribrosa. While electron microscopy of the optic nerve anatomy has not demonstrated a communication between the 2 spaces, one case report has demonstrated bilateral optic nerve sheath hemorrhages following rupture of an anterior choroidal artery aneurysm resulting in a Terson syndrome.[2] Pathological specimens have not shown any blood in the optic nerve sheath within 3 mm of the globe.

Another mechanism suggests that a sudden rise in the venous pressure caused by the intracerebral bleeding is transmitted to the eye and results in intraocular bleeding. However, experimental studies have shown that the intravenous pressures are not high enough to create an intraocular hemorrhage.

The sudden rise in intracranial pressure is probably the primary inciting event in Terson syndrome. Intracranial pressure is transmitted through the optic nerve sheath to the swollen optic nerve head, which occludes the retinal and choroidal anastomoses at the level of the lamina cribrosa. The elevated venous pressure generated in the retinal venous system is assumed to rupture the superficial retinal vessels, resulting in intraocular hemorrhages.

A case report supports this theory by demonstrating peripapillary fluorescein leakage in a patient with vitreous hemorrhage secondary to a subarachnoid hemorrhage.[3] Because of these assumptions regarding the pathogenesis of the syndrome, the definition of Terson syndrome now includes any intraocular hemorrhage associated with intracranial bleeding and acutely increased intracranial pressure. Attempts have been made to correlate Terson syndrome with the intraocular hemorrhages seen in shaken baby syndrome because of the similarity in clinical findings in the eye and the brain, but acute tractional forces may be an additional factor contributing to the intraocular hemorrhage in the latter.

Previous
Next

Presentation

The neurologic symptoms are related to intracranial bleeding. Reported visual acuities range from 20/20 to light perception, but they often are difficult to obtain secondary to the impaired neurologic status of the patient. The degree of visual loss is related to the degree and extent of the intraocular hemorrhage.

The intraocular hemorrhage is usually bilateral and superficial to the retina. Intraretinal or subretinal hemorrhages have been reported but are less frequent. Preretinal hemorrhage can develop into vitreous hemorrhage weeks after the initial inciting event. The intraocular hemorrhage may be difficult to diagnose immediately because the ophthalmologist is restricted from dilating the patient for neurologic monitoring. A decreased red reflex is helpful in evaluating a patient who is comatose, and B-scan ultrasound can further establish the extent of vitreous hemorrhage.

Previous
Next

Indications

Strict guidelines for treatment have not been established by clinical studies. Patients usually have responded well to observation.

Indications for a vitrectomy include the following:

  • Nonclearing vitreous hemorrhage in patient who is monocular
  • Subfoveal hemorrhage
  • Retinal detachment with vitreous hemorrhage
  • Prevention of amblyopia in pediatric patients
  • Late complications of intraocular hemorrhage, such as epiretinal membrane formation (macular pucker)
  • Occupational necessity for rapidly cleared vision
Previous
Next

Relevant Anatomy

The relevant anatomy in Terson syndrome includes the inner retinal vasculature, choroidal vasculature, chorioretinal anastomoses near the optic nerve head, and subarachnoid space surrounding the optic nerve.

Previous
Next

Contraindications

Contraindications for a vitrectomy include a small intraocular hemorrhage with a high likelihood of spontaneous clearing and an intraocular hemorrhage that is spontaneously clearing.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Richard J Ou, MD  Clinical Assistant Professor, Baylor College of Medicine; Attending Physician and Consultant, Michael E DeBakey Veterans Affairs Medical Center

Richard J Ou, MD is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, Harris County Medical Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Marc O Yoshizumi, MD  Director of Eye Trauma and Emergency Center, Professor, Department of Ophthalmology, Jules Stein Eye Institute, University of California at Los Angeles

Marc O Yoshizumi, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Specialty Editor Board

Brian A Phillpotts, MD  Former Vitreo-Retinal Service Director, Former Program Director, Clinical Assistant Professor, Department of Ophthalmology, Howard University College of Medicine

Brian A Phillpotts, MD is a member of the following medical societies: American Academy of Ophthalmology, American Diabetes Association, American Medical Association, and National Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Steve Charles, MD  Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine; Adjunct Professor of Ophthalmology, Columbia College of Physicians & Surgeons; Clinical Professor Ophthalmology, Chinese University of Hong Kong

Steve Charles, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Club Jules Gonin, Macula Society, and Retina Society

Disclosure: Alcon Laboratories Consulting fee Consulting; OptiMedica Ownership interest Consulting

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Litten M. Ueber einige vom allegmein-klinischen Standpunkt aus interessante Augenveranderungen. Berl Klin Wochnschr. 1881;18:23-27.

  2. Gauntt CD, Sherry RG, Kannan C. Terson syndrome with bilateral optic nerve sheath hemorrhage. J Neuroophthalmol. Sep 2007;27(3):193-4. [Medline].

  3. Ogawa T, Kitaoka T, Dake Y, et al. Terson syndrome: a case report suggesting the mechanism of vitreous hemorrhage. Ophthalmology. Sep 2001;108(9):1654-6. [Medline].

  4. Schultz PN, Sobol WM, Weingeist TA. Long-term visual outcome in Terson syndrome. Ophthalmology. Dec 1991;98(12):1814-9. [Medline].

  5. Fahmy JA. Fundal haemorrhages in ruptured intracranial aneurysms. I. Material, frequency and morphology. Acta Ophthalmol (Copenh). 1973;51(3):289-98. [Medline].

  6. Fahmy JA. Fundal haemorrhages in ruptured intracranial aneurysms. II. Correlation with the clinical course. Acta Ophthalmol (Copenh). 1973;51(3):299-304. [Medline].

  7. Frizzell RT, Kuhn F, Morris R, et al. Screening for ocular hemorrhages in patients with ruptured cerebral aneurysms: a prospective study of 99 patients. Neurosurgery. Sep 1997;41(3):529-33; discussion 533-4. [Medline].

  8. Garcia-Arumi J, Corcostegui B, Tallada N, et al. Epiretinal membranes in Tersons syndrome. A clinicopathologic study. Retina. 1994;14(4):351-5. [Medline].

  9. Garweg JG, Koerner F. Outcome indicators for vitrectomy in Terson syndrome. Acta Ophthalmol. Mar 2009;87(2):222-6. [Medline].

  10. Gnanaraj L, Tyagi AK, Cottrell DG, et al. Referral delay and ocular surgical outcome in Terson syndrome. Retina. 2000;20(4):374-7. [Medline].

  11. Heyreh SS. An experimental study of the central retinal vein occlusion. Trans Ophthalmol Soc UK. 1964;84:586-98.

  12. Hoving EW, Rahmani M, Los LI, Renardel de Lavalette VW. Bilateral retinal hemorrhage after endoscopic third ventriculostomy: iatrogenic Terson syndrome. J Neurosurg. May 2009;110(5):858-60. [Medline].

  13. Khan SG, Frenkel M. Intravitreal hemorrhage associated with rapid increase in intracranial pressure (Terson's syndrome). Am J Ophthalmol. Jul 1975;80(1):37-43. [Medline].

  14. Kuhn F, Morris R, Witherspoon CD, et al. Terson syndrome. Results of vitrectomy and the significance of vitreous hemorrhage in patients with subarachnoid hemorrhage. Ophthalmology. Mar 1998;105(3):472-7. [Medline].

  15. McCarron MO, Alberts MJ, McCarron P. A systematic review of Terson's syndrome: frequency and prognosis after subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. Mar 2004;75(3):491-3. [Medline].

  16. Medele RJ, Stummer W, Mueller AJ, et al. Terson's syndrome in subarachnoid hemorrhage and severe brain injury accompanied by acutely raised intracranial pressure. J Neurosurg. May 1998;88(5):851-4. [Medline].

  17. Ness T, Janknecht P, Berghorn C. Frequency of ocular hemorrhages in patients with subarachnoidal hemorrhage. Graefes Arch Clin Exp Ophthalmol. Sep 2005;243(9):859-62. [Medline].

  18. Pfausler B, Belcl R, Metzler R, et al. Terson's syndrome in spontaneous subarachnoid hemorrhage: a prospective study in 60 consecutive patients. J Neurosurg. Sep 1996;85(3):392-4. [Medline].

  19. Rubowitz A, Desai U. Nontraumatic macular holes associated with Terson syndrome. Retina. Feb 2006;26(2):230-2. [Medline].

  20. Sharma T, Gopal L, Biswas J, Shanmugam MP, Bhende PS, Agrawal R, et al. Results of vitrectomy in Terson syndrome. Ophthalmic Surg Lasers. May-Jun 2002;33(3):195-9. [Medline].

  21. Shaw HE Jr, Landers MB, Sydnor CF. The significance of intraocular hemorrhages due to subarachnoid hemorrhage. Ann Ophthalmol. Nov 1977;9(11):1403-5. [Medline].

  22. Toosi SH, Malton M. Terson's syndrome--significance of ocular findings. Ann Ophthalmol. Jan 1987;19(1):7-12. [Medline].

  23. Vrabec TR, Sergott RC, Savino PJ, et al. Intermittent obstructive hydrocephalus in the Arnold-Chiari malformation. Ann Neurol. Sep 1989;26(3):401-4. [Medline].

  24. Weingeist TA, Goldman EJ, Folk JC, et al. Terson's syndrome. Clinicopathologic correlations. Ophthalmology. Nov 1986;93(11):1435-42. [Medline].

Previous
Next
 
Right eye of a 28-year-old female with subarachnoid hemorrhage 1 week after intracranial surgery.
Left eye of a 28-year-old female with subarachnoid hemorrhage 1 week after intracranial surgery.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.